Saturday, October 3, 2026

USD/EUR Drops By 2% In The Last 21 Sessions

USD/EUR Drops By 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.08% for the last 21 sessions. At 00:12 EST on Friday, 21 July, USD/EUR (USDEUR) is $0.90.

USD/EUR's yearly highs and lows, it's 1.218% up from its 52-week low and 14.358% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.14%, a negative 0.09%, and a positive 0.33%, respectively.

USD/EUR's highest amplitude of average volatility was 0.20% (last week), 0.35% (last month), and 0.33% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd: room to correct lower before the end of the week – ING. According to FXStreet on Wednesday, 19 July, "For now, they've preferred to keep expectations close to two rate hikes (43 bps) as EUR/USD has held above 1.1200 thanks to the Dollar's still softish momentum.", "We still see room for the overvalued EUR/USD (in the short-term) to correct lower before the end of the week, with a move back to the 1.1150/1.1170 region as a first step."
  • Eur/usd price analysis: bulls flirt with 100-hour SMA support breakpoint, around 1.1225 area. According to FXStreet on Thursday, 20 July, "From a technical perspective, the overnight breakdown through a three-week-old trading range and the 100-hour Simple Moving Average (SMA) warrants some caution before placing fresh bullish bets around the EUR/USD pair. ", "This, in turn, is seen as a key factor acting as a tailwind for the EUR/USD pair, though less hawkish remarks by several European Central Bank (ECB) policymakers this week could cap any meaningful gains, at least for the time being."
  • Eur/usd forex signal: on the cusp of a short-term pullback - 19 July 2023. According to DailyForex on Wednesday, 19 July, "The EUR/USD price was trading at 1.1225, a few pips below this week's high of 1.1275.", "The EUR/USD price will also react to the latest European consumer inflation data. "
  • According to FXStreet on Wednesday, 19 July, "Price action in EUR/USD pair hints at the idea that further gains might be in store in the short-term horizon.", "Furthermore, the constructive view of EUR/USD appears unchanged as long as the pair trades above the key 200-day SMA."
  • Eur/usd extends pullback from 1.1280 resistance as ECB vs. fed divergence appears dicey. According to FXStreet on Wednesday, 19 July, "It's worth observing that mixed headlines surrounding China and optimism at the equity markets also tease the EUR/USD bears amid a sluggish session. ", "With this, the EUR/USD is likely to extend the latest pullback amid a light calendar."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com